Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EC device and drug units set up joint working group

This article was originally published in Clinica

Executive Summary

The European Commission's unit responsible for medical devices is looking forward to the move to Directorate F facilitating the setting up a joint working group with its colleagues in the pharmaceutical unit within the same Directorate on drug/device borderline issues. (The devices unit already has its own working group on borderline issues.) In particular, there will need to be talks between the two different units to review the existing borderline products demarcation guidelines.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts